Mark James Lawday - 31 Dec 2023 Form 5 Insider Report for LUXFER HOLDINGS PLC (LXFR)

Role
Vice President and General Manager, Luxfer Gas Cylinders - Europe
Signature
/s/ Megan E. Glise under Power of Attorney for Mark J. Lawday
Issuer symbol
LXFR
Transactions as of
31 Dec 2023
Net transactions value
-$30,315
Form type
5
Filing time
14 Feb 2024, 17:43:17 UTC
Previous filing
20 Mar 2023
Next filing
18 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXFR Ordinary Shares Options Exercise +750 +40% 2,648 08 May 2023 Direct F1, F2
transaction LXFR Ordinary Shares Options Exercise +181 +6.8% 2,829 08 May 2023 Direct F1, F3
transaction LXFR Ordinary Shares Options Exercise +500 +18% 3,329 08 May 2023 Direct F1, F2
transaction LXFR Ordinary Shares Options Exercise +93 +2.8% 3,422 08 May 2023 Direct F1, F3
transaction LXFR Ordinary Shares Options Exercise +800 +23% 4,222 08 May 2023 Direct F1, F2
transaction LXFR Ordinary Shares Options Exercise +31 +0.73% 4,253 08 May 2023 Direct F1, F3
transaction LXFR Ordinary Shares Options Exercise +750 +18% 5,003 08 May 2023 Direct F1, F2
transaction LXFR Ordinary Shares Options Exercise +24 +0.48% 5,027 08 May 2023 Direct F1, F3
transaction LXFR Ordinary Shares Tax liability $23,889 -1,613 -32% $14.81 3,414 08 May 2023 Direct F4
transaction LXFR Ordinary Shares Sale $6,426 -525 -15% $12.24 2,889 09 Aug 2023 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXFR Stock Options (Right to Buy) Options Exercise -750 -100% 0 08 May 2023 Ordinary Shares 750 Direct F2, F6
transaction LXFR Dividend Equivalent Rights Options Exercise -181 -100% 0 08 May 2023 Ordinary Shares 181 Direct F3, F7, F8
transaction LXFR Stock Options (Right to Buy) Options Exercise -500 -50% 500 08 May 2023 Ordinary Shares 500 Direct F2, F9, F10
transaction LXFR Dividend Equivalent Rights Options Exercise -93 -65% 51 08 May 2023 Ordinary Shares 93 Direct F3, F7, F11, F12
transaction LXFR Stock Options (Right to Buy) Options Exercise -800 -50% 800 08 May 2023 Ordinary Shares 800 Direct F2, F13
transaction LXFR Dividend Equivalent Rights Options Exercise -31 -26% 87 08 May 2023 Ordinary Shares 31 Direct F3, F7, F14
transaction LXFR Stock Options (Right to Buy) Options Exercise -750 -25% 2,250 08 May 2023 Ordinary Shares 750 Direct F2, F15
transaction LXFR Dividend Equivalent Rights Options Exercise -24 -11% 190 08 May 2023 Ordinary Shares 24 Direct F3, F7, F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the exercise of Stock Options and related Dividend Equivalent Rights on May 8, 2023, as detailed in Table II of this Form 5. This transaction was not previously reported on Form 4 due to an inadvertent administrative error.
F2 Stock Options convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
F3 Dividend Equivalent Rights convert 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
F4 Represents the payment of exercise price and tax liabilities by withholding Ordinary Shares incident to the exercise of derivative securities on May 8, 2023. This transaction was not previously reported on Form 4 due to an inadvertent administrative error.
F5 Represents the on-market sale of 525 Ordinary Shares on August 9, 2023. This transaction was not previously reported on Form 4 due to an inadvertent administrative error.
F6 The subject Stock Options fully vested and became exercisable on March 14, 2023.
F7 Represents Dividend Equivalent Rights accrued on Stock Options, which become exercisable proportionately with the Stock Options to which they relate. Each Dividend Equivalent Right is the economic equivalent of one Ordinary Share, subject to a nominal payment of $1.00 per Ordinary Share.
F8 The subject Dividend Equivalent Rights fully vested and became exercisable on March 14, 2023.
F9 The subject Stock Options vested and became exercisable on December 13, 2022.
F10 The subject Stock Options fully vested and became exercisable on December 13, 2023. As of December 31, 2023, the Stock Options have not been exercised.
F11 The subject Dividend Equivalent Rights vested and became exercisable on December 13, 2020, December 13, 2021, and December 13, 2022.
F12 The subject Dividend Equivalent Rights fully vested and became exercisable on December 13, 2023. As of December 31, 2023, the Dividend Equivalent Rights have not been exercised.
F13 The subject Stock Options vested and became exercisable in equal installments on March 15, 2022 and March 15, 2023. The remaining Stock Options will vest and become exercisable in two equal annual installments on March 15, 2024 and March 15, 2025.
F14 The subject Dividend Equivalent Rights vested and became exercisable on March 15, 2022 and March 15, 2023. The remaining Dividend Equivalent Rights will vest and become exercisable in two annual installments on March 15, 2024 and March 15, 2025.
F15 The subject Stock Options vested and became exercisable on March 14, 2023. The remaining Stock Options vest and become exercisable in three equal annual installments beginning on March 14, 2024.
F16 The subject Dividend Equivalent Rights vested and became exercisable on March 14, 2023. The remaining Dividend Equivalent Rights will vest and become exercisable in three annual installments beginning on March 14, 2024.

Remarks:

Vice President and General Manager, Luxfer Gas Cylinders - Europe